Literature DB >> 27154427

Modeling intraocular bacterial infections.

Roger A Astley1, Phillip S Coburn1, Salai Madhumathi Parkunan2, Michelle C Callegan3.   

Abstract

Bacterial endophthalmitis is an infection and inflammation of the posterior segment of the eye which can result in significant loss of visual acuity. Even with prompt antibiotic, anti-inflammatory and surgical intervention, vision and even the eye itself may be lost. For the past century, experimental animal models have been used to examine various aspects of the pathogenesis and pathophysiology of bacterial endophthalmitis, to further the development of anti-inflammatory treatment strategies, and to evaluate the pharmacokinetics and efficacies of antibiotics. Experimental models allow independent control of many parameters of infection and facilitate systematic examination of infection outcomes. While no single animal model perfectly reproduces the human pathology of bacterial endophthalmitis, investigators have successfully used these models to understand the infectious process and the host response, and have provided new information regarding therapeutic options for the treatment of bacterial endophthalmitis. This review highlights experimental animal models of endophthalmitis and correlates this information with the clinical setting. The goal is to identify knowledge gaps that may be addressed in future experimental and clinical studies focused on improvements in the therapeutic preservation of vision during and after this disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotics; Bacteria; Corticosteroids; Endophthalmitis; Inflammation; Therapeutics; Vitrectomy

Mesh:

Substances:

Year:  2016        PMID: 27154427      PMCID: PMC4992594          DOI: 10.1016/j.preteyeres.2016.04.007

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  189 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

Review 2.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

3.  Intraocular penetration of streptomycin following systemic and local administration.

Authors:  I H LEOPOLD; A NICHOLS
Journal:  Arch Ophthal       Date:  1946-01

4.  Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial.

Authors:  E Albrecht; J C Richards; T Pollock; C Cook; L Myers
Journal:  Br J Ophthalmol       Date:  2011-02-02       Impact factor: 4.638

5.  Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis.

Authors:  B D Jett; H G Jensen; R E Nordquist; M S Gilmore
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 6.  Evidence for and against intravitreous corticosteroids in addition to intravitreous antibiotics for acute endophthalmitis.

Authors:  Diem K Bui; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

7.  Cytokine expression in a rat model of Staphylococcus aureus endophthalmitis.

Authors:  M J Giese; H L Sumner; J A Berliner; B J Mondino
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

8.  Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.

Authors:  Regis P Kowalski; Eric G Romanowski; Francis S Mah; Kathleen A Yates; Y Jerold Gordon
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

9.  Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits.

Authors:  S S Park; N Samiy; K Ruoff; D J D'Amico; A S Baker
Journal:  Arch Ophthalmol       Date:  1995-10

10.  Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases.

Authors:  Matthew S Benz; Ingrid U Scott; Harry W Flynn; Nichard Unonius; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

View more
  20 in total

Review 1.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

2.  The role of pili in Bacillus cereus intraocular infection.

Authors:  Michelle C Callegan; Salai Madhumathi Parkunan; C Blake Randall; Phillip S Coburn; Frederick C Miller; Austin L LaGrow; Roger A Astley; Craig Land; So-Young Oh; Olaf Schneewind
Journal:  Exp Eye Res       Date:  2017-03-20       Impact factor: 3.467

3.  Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis.

Authors:  Sarah John; Oliver H Bell; Leslie Wilson; David A Copland; Kathryn L Pepple
Journal:  J Vis Exp       Date:  2021-12-17       Impact factor: 1.355

Review 4.  Cytokine Expression in Staphylococcal and Streptococcal Endophthalmitis.

Authors:  Marcus Y Soon; Penelope J Allen; Rosie C H Dawkins
Journal:  Biomed Hub       Date:  2022-07-04

5.  The Bacillus virulome in endophthalmitis.

Authors:  Phillip S Coburn; Frederick C Miller; Morgan A Enty; Craig Land; Austin L LaGrow; Md Huzzatul Mursalin; Michelle C Callegan
Journal:  Microbiology (Reading)       Date:  2021-05       Impact factor: 2.777

6.  A Novel Biomimetic Nanosponge Protects the Retina from the Enterococcus faecalis Cytolysin.

Authors:  Austin L LaGrow; Phillip S Coburn; Frederick C Miller; Craig Land; Salai Madhumathi Parkunan; Brian T Luk; Weiwei Gao; Liangfang Zhang; Michelle C Callegan
Journal:  mSphere       Date:  2017-11-22       Impact factor: 4.389

Review 7.  From Immunologically Archaic to Neoteric Glycovaccines.

Authors:  Marco Cavallari; Gennaro De Libero
Journal:  Vaccines (Basel)       Date:  2017-01-27

8.  Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis.

Authors:  Md Huzzatul Mursalin; Erin Livingston; Phillip S Coburn; Frederick C Miller; Roger Astley; Michelle C Callegan
Journal:  J Vis Exp       Date:  2021-02-06       Impact factor: 1.355

9.  Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection.

Authors:  Sukhvinder Singh; Pawan Kumar Singh; Alokkumar Jha; Poonam Naik; Joveeta Joseph; Shailendra Giri; Ashok Kumar
Journal:  Cell Rep Med       Date:  2021-05-18

10.  Immune Inhibitor A Metalloproteases Contribute to Virulence in Bacillus Endophthalmitis.

Authors:  Erin T Livingston; Md Huzzatul Mursalin; Phillip S Coburn; Roger Astley; Frederick C Miller; Omar Amayem; Didier Lereclus; Michelle C Callegan
Journal:  Infect Immun       Date:  2021-06-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.